ORIC Pharmaceuticals, Inc.
ORIC
$10.08
$0.232.34%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -21.10% | 17.31% | -5.04% | -8.14% | -27.80% |
| Total Depreciation and Amortization | 2.65% | -0.66% | 12.59% | -0.74% | 4.21% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.48% | 58.92% | 14.76% | 15.19% | -1.14% |
| Change in Net Operating Assets | 90.81% | -293.74% | 83.34% | -29.03% | 141.21% |
| Cash from Operations | 5.20% | -15.97% | 2.58% | -12.38% | 15.11% |
| Capital Expenditure | 83.72% | -76.71% | 47.61% | -25.53% | -52.75% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -436.59% | -46.73% | 82.54% | 26.19% | 130.19% |
| Cash from Investing | -442.67% | -47.37% | 84.89% | 26.20% | 129.55% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 53,147.43% | -56.00% | 356.35% | -84.56% | -99.35% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -71.07% | -- | -- | -- | 100.00% |
| Cash from Financing | 1,220,827.27% | -98.09% | 356.35% | -84.56% | -99.35% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 363.40% | -166.37% | 370.95% | 14.21% | -119.80% |